PEOPLE AFFILIATED WITH THE CENTER FOR TRANSLATIONAL CANCER RESEARCH
The Center for Translational Cancer Research
PEOPLE AFFILIATED WITH THE CENTER FOR TRANSLATIONAL CANCER RESEARCH
Researchers: Our researchers use a multidisciplinary approach to investigate the basic molecular mechanisms of cancer cell biology with a mind toward translating their discoveries into new ideas that can be applied to cutting edge clinical cancer research.
Educators | More: Our faculty not only perform translational research, but also teach in a variety of courses offered to students at the University of Delaware, including specialized courses in cancer biology. Our educators embrace problem-based learning strategies and include current medical literature in their 400, 600 and 800 level courses.
Clinicians: Our clinicians are experienced surgeons, radiation and medical oncologists, research nurses, patient care coordinators, pyschologists, and genetic counselors who work with researchers in a multidisciplinary center based approach that brings the best available care to the cancer patient. Our clinicians participate in clinical trials through the CCOP program.
Students: Our students include some of the best undergraduate researchers in the country, M.S. and Ph.D. students in a variety of programs who are funded from a variety of training grants including those from the NIH, NSF, DOD and the Howard Hughes Medical Institute Fellowship Program.
Post-doctoral fellows: Our postdoctoral and clinical fellows include Ph.D. and M.D. holding trainees who are actively engaged in incorporating both basic and applied concepts of cancer biology into their individual research projects. Multidisciplinary projects are supported by various training grants and are encouraged.
Biotechnicians: Our technicians are highly trained experimentalists who assist our researchers in the development of new tools for translational cancer research. An emphasis is placed on new biomarkers for assessment of risk in patient specimens and on using new information from the human genome for personalized medicine.
We are...
